ATAI vs. DCTH

Last updated Apr 2, 2026

Compare and contrast key facts about Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH).

Performance

ATAI vs. DCTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH). The values are adjusted to include any dividend payments, if applicable.

ATAI vs. DCTH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ATAI Atai Life Sciences N.V.	-9.54%	207.52%	-5.67%	-46.99%	-65.14%	-60.77%
DCTH Delcath Systems, Inc.	-5.54%	-16.11%	189.42%	15.56%	-53.55%	-23.95%

Fundamentals

Market Cap ATAI : $1.16B DCTH : $347.69M
EPS ATAI : -$2.72 DCTH : $0.07
PS Ratio ATAI : 219.71 DCTH : 5.76
PB Ratio ATAI : 5.24 DCTH : 3.13
Total Revenue (TTM) ATAI : $4.09M DCTH : $64.50M
Gross Profit (TTM) ATAI : $3.08M DCTH : $73.43M
EBITDA (TTM) ATAI : -$113.05M DCTH : $1.61M

Returns By Period

In the year-to-date period, ATAI achieves a -9.54% return, which is significantly lower than DCTH's -5.54% return.

ATAI

• 1D: 4.52%
• 1M: 0.54%
• YTD: -9.54%
• 6M: -28.85%
• 1Y: 198.39%
• 3Y*: 26.91%
• 5Y*: —
• 10Y*: —

DCTH

• 1D: 2.80%
• 1M: 6.83%
• YTD: -5.54%
• 6M: -11.26%
• 1Y: -24.11%
• 3Y*: 18.38%
• 5Y*: -4.88%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ATAI vs. DCTH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATAI

ATAI Risk / Return Rank: 88
ATAI Sharpe Ratio Rank: 93
ATAI Sortino Ratio Rank: 91
ATAI Omega Ratio Rank: 87
ATAI Calmar Ratio Rank: 88
ATAI Martin Ratio Rank: 82

DCTH

DCTH Risk / Return Rank: 25
DCTH Sharpe Ratio Rank: 22
DCTH Sortino Ratio Rank: 23
DCTH Omega Ratio Rank: 23
DCTH Calmar Ratio Rank: 26
DCTH Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATAI vs. DCTH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ATAI	DCTH	Difference
Sharpe ratio Return per unit of total volatility	2.35	-0.41	+2.77
Sortino ratio Return per unit of downside risk	2.97	-0.28	+3.25
Omega ratio Gain probability vs. loss probability	1.36	0.97	+0.40
Calmar ratio Return relative to maximum drawdown	3.58	-0.46	+4.04
Martin ratio Return relative to average drawdown	6.67	-0.65	+7.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ATAI vs. DCTH - Sharpe Ratio Comparison

The current ATAI Sharpe Ratio is 2.35, which is higher than the DCTH Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of ATAI and DCTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ATAI	DCTH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.35	-0.41	+2.77
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.07	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.35	-0.45	+0.10

Correlation

The correlation between ATAI and DCTH is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ATAI vs. DCTH - Dividend Comparison

Neither ATAI nor DCTH has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ATAI vs. DCTH - Drawdown Comparison

The maximum ATAI drawdown since its inception was -94.77%, smaller than the maximum DCTH drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ATAI and DCTH.

Drawdown Indicators

	ATAI	DCTH	Difference
Max Drawdown Largest peak-to-trough decline	-94.77%	-99.96%	+5.19%
Max Drawdown (1Y) Largest decline over 1 year	-48.06%	-54.75%	+6.69%
Max Drawdown (5Y) Largest decline over 5 years	—	-85.10%	—
Current Drawdown Current decline from peak	-81.40%	-99.84%	+18.44%
Average Drawdown Average peak-to-trough decline	-79.80%	-96.38%	+16.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.79%	38.37%	-12.58%

Volatility

ATAI vs. DCTH - Volatility Comparison

Atai Life Sciences N.V. (ATAI) has a higher volatility of 21.20% compared to Delcath Systems, Inc. (DCTH) at 12.38%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than DCTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ATAI	DCTH	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.20%	12.38%	+8.82%
Volatility (6M) Calculated over the trailing 6-month period	53.28%	36.55%	+16.73%
Volatility (1Y) Calculated over the trailing 1-year period	85.32%	58.46%	+26.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	84.10%	74.16%	+9.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	84.10%	111.18%	-27.08%

Financials